← SynDRA
VOLASERTIB
SynDRA canonical compound SYN0024283 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | PLK1 |
|---|
| Mechanism of action | PLK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PLK inhibitor
- PLK1 INHIBITOR
- Serine/threonine-protein kinase PLK1 inhibitor
- PLK1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AAK1
- PGRMC1
- PEBP1
- PDXK
- PDGFRB
- PCYT1A
- PASK
- PAK4
- PAK2
- PAICS
- OPA1
- OLA1
- NUAK2
- NTRK1
- NQO2
- NLK
- NEK9
- PFKP
- PHKG2
- NEK3
- PIM1
- PRKAR2A
- PRKAG2
- PRKAG1
- PRKACB
- PRKACA
- PRKAA1
- PLK4
- PLK3
- PLK2
- PKN3
- PKN2
- PKN1
- PKMYT1
- PIP4K2C
- PIP4K2A
- NEK7
- NEK2
- ABL1
- MAPKAPK5
Cross-references
Synonyms
- BI-6727
- BI6727
- BI6727 (Volasertib)
- Volasertib (BI 6727)
- UNII-6EM57086EA
- 6EM57086EA
- N-{trans-4-[4-(Cyclopropylmethyl)piperazin-1-Yl]cyclohexyl}-4-{[(7r)-7-Ethyl-5-Methyl-8-(1-Methylethyl)-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxybenzamide
- Volasertib [USAN:INN]
- IBI
- Volasertib (USAN)
- BI6727,Volasertib
- Volasertib(BI6727)
- BI6727 - Volasertib
- Volasertib (BI6727)
- BI6727 (Volasertib)/
- BI 6727 (Volasertib)
- MLS006011195
- SCHEMBL738946
- SCHEMBL9888052
- SCHEMBL2169101
- GTPL7947
- Volasertib [USAN]
- Bi6727(volasertib)
- Benzamide, N-(trans-4-(4-(cyclopropylmethyl)-1-piperazinyl)cyclohexyl)-4-(((7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl)amino)-3-methoxy-
- N-((1s,4S)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexyl)-4-(((R)-7-ethyl-8-isopropyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)amino)-3-methoxybenzamide
- N-(Trans-4-(4-(cyclopropylMethyl)piperazin-1-yl)cyclohexyl)-4-(((R)-7-ethyl-8-isopropyl-5-Methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)aMino)-3-MethoxybenzaMide
- VOLASERTIB [INN]
- VOLASERTIB [WHO-DD]
- CHEMBL1233528
- CHEMBL4284151
- SCHEMBL21916558
- BCPP000341
- DTXSID801099395
- DTXSID901025694
- BCP02405
- EX-A1364
- BDBM50402023
- MFCD20926414
Look up VOLASERTIB in the interactive SynDRA portal →